SwissTAVI Registry: Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Native aortic valve stenosis
• Native aortic valve regurgitation
• Degenerated aortic bioprosthesis requiring treatment
Locations
Other Locations
Switzerland
Department of Cardiology
RECRUITING
Bern
Department of Cardiology
RECRUITING
Bern
Contact Information
Primary
Stefan Stortecky, MD
stefan.stortecky@insel.ch
0041 31 632 83 52
Backup
Stephan Windecker, MD
stephan.windecker@insel.ch
0041 31 632 83 52
Time Frame
Start Date: 2011-02
Estimated Completion Date: 2025-05
Participants
Target number of participants: 20000
Treatments
1
Patients with native aortic stenosis undergoing TAVI
2
Patients with native aortic regurgitation undergoing TAVI
3
Patients with degenerative surgical bioprosthesis undergoing TAV-in-SAV
Authors
Related Therapeutic Areas
Sponsors
Leads: Insel Gruppe AG, University Hospital Bern